curbside consult prostate cancer

Curbside Consult: Episode 1, Part 1

58 Year-Old African American with LUTS. To PSA or Not To PSA? Part 1

Herbert Lepor, MD, and Danil V. Makarov, MD, MHS, discuss the case of a 58 year-old African American male with lower urinary tract symptoms in Part 1 of this episode of Curbside Consult. They delve into whether a PSA test should be conducted, focusing on key risk factors for this particular patient. The faculty also cover results from the PLCO study and the ESRPC study with key takeaways about weighing the risks and benefits of preventive testing in prostate cancer.

 Learn more about Herbert Lepor, MD.

 Learn more about Danil V.Makarov, MD, MHS.

 

Related Reading

Schröder FH, Hugosson J, Roobol MJ, et al. (2009) Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360:1320–1328.

Andriole GL, Crawford ED, Grubb RL 3rd., et al. (2009) Mortality results from a randomized prostate-cancer screening trial. N Engl J Med360:1310–1319.

Faculty

Herbert Lepor

Herbert Lepor, MD

Martin Spatz Chariman of the Department of Urology

Professor of Urology

Professor of Pharmacology

Director, Smilow Comprehensive Prostate Cancer Center

NYU Langone Medical Center

Danil V. Makarov

Danil V Makarov, MD, MHS

Assistant Professor of Urology and Health Policy

Director, Division of Urological Health Services Research, Department of Urology

NYU Langone Medical Center